Skip to content

Author

Matthew D. Richard

We have 2 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

A novel KIR3DL2-directed CAR T-cell therapy for cutaneous and systemic T-cell lymphomas

Chimeric antigen receptor (CAR) T-cell therapy has transformed the treatment of B-cell malignancies and multiple myeloma, but its extension to T-cell lymphomas (TCLs) has been constrained by the paucity of antigens that can be safely targeted. While targeting pan-T antigens broadens the therapeutic reach across various...

Federico Mario Aletti, J. Weng, Cuong Le et al. · 0 citations
Sep 2026

Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion.

High frequencies of pre‑existing, recipient-derived alloreactive CD8+ T cells mediated rapid CAR T rejection in non-expanders and effector-like features, rather than stem/central memory programs, drove robust clonal CAR T expansion consistently across expanders.

A. Jallouk, Zhong-Qi Ge, V. Kaimal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.